Helaine Fingold Quoted in “VBID Model Could Boost Quality Metrics for MA Plans, Industry Observers Tell AIS Newsletter”

AIS Health

Helaine I. Fingold, a Senior Counsel in the Health Care and Life Sciences practice, in the firm’s Baltimore office, was quoted in AIS Health, in “VBID Model Could Boost Quality Metrics for MA Plans, Industry Observers Tell AIS Newsletter.”

Following is an excerpt:

Plans could improve health outcomes for enrollees, perhaps improving their quality metrics at the same time, Helaine Fingold, an attorney with Epstein Becker Green in Baltimore, tells VBC. “To the extent that a plan’s VBID project does in fact improve financial outcomes, this might allow the plan to use any savings achieved to offer a more attractive benefit package,” she says. “VBID has the potential to help plan sponsors achieve better financial outcomes as well as better health outcomes for enrollees, as it has been shown to do in some employer plans.”

Larger MA plans may get more of a return on investment from participation, compared with smaller plans, Fingold continues. Also, a plan with a larger percentage of enrollees with the targeted diagnoses might be able to get results that are more statistically significant, although “it would really depend on the nature of each plan’s enrollment” and which of the four CMS-approved VBID intervention approaches the plan uses.